发明名称 |
Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement |
摘要 |
The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy. |
申请公布号 |
US9220691(B2) |
申请公布日期 |
2015.12.29 |
申请号 |
US200712446887 |
申请日期 |
2007.10.10 |
申请人 |
LTS LOHMANN THERAPIE SYSTEME AG |
发明人 |
Theobald Frank;Eifler René |
分类号 |
A61K31/567;A61P15/18;A61K9/70;A61P5/34;A61K31/565;A61K31/57 |
主分类号 |
A61K31/567 |
代理机构 |
Frommer Lawrence & Haug LLP |
代理人 |
Frommer Lawrence & Haug LLP |
主权项 |
1. A transdermal therapeutic system for administration of norelgestromin and ethinyl estradiol, the transdermal therapeutic system comprising:
a norelgestromin and ethinyl estradiol-impermeable backing layer; at least one norelgestromin and ethinyl estradiol-containing matrix layer; and optionally a detachable protective layer; wherein the matrix layer is consisting of:
a) a therapeutically effective dose of norelgestromin and ethinyl estradiol;b) a pressure-sensitive silicon adhesive;c) diethylene glycol monoethyl ether;d) DL-α-tocopherol;e) polyvinylpyrrolidone; andf) sodium laurate. |
地址 |
Andernach DE |